PHAR vs AAPL: Which Stock is Better?
Side-by-side comparison of Pharming Group Nv and Apple Inc in 2026
PHAR
Pharming Group Nv
$17.34
AAPL
Apple Inc
$269.84
Key Metrics Comparison
| Metric | PHAR | AAPL | Winner |
|---|---|---|---|
| Market Cap | $1.22B | N/A | PHAR |
| P/E Ratio | 433.50 | 33.32 | AAPL |
| EPS (TTM) | $0.04 | $8.11 | AAPL |
| Revenue Growth | 0.1% | 0.2% | AAPL |
| Gross Margin | 87.9% | 47.3% | PHAR |
Analyze PHAR
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAR or AAPL a better investment?
Comparing PHAR and AAPL: Pharming Group Nv has a market cap of $1.22B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAR and AAPL?
PHAR (Pharming Group Nv) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAR or AAPL?
Based on P/E ratios, AAPL trades at a lower multiple (33.3x vs 433.5x).
Which is growing faster: PHAR or AAPL?
AAPL has higher revenue growth at 0.2% vs 0.1% for PHAR.
Which company is more profitable: PHAR or AAPL?
Pharming Group Nv (PHAR) has higher gross margins at 87.9% compared to 47.3% for AAPL.
Which is the larger company: PHAR or AAPL?
Pharming Group Nv (PHAR) is larger with a market cap of $1.22B compared to N/A for AAPL.
Should I buy PHAR or AAPL in 2026?
Both PHAR and AAPL have investment merit. PHAR trades at $17.34 while AAPL trades at $269.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAR and AAPL stock?
Key differences: Market Cap ($1.22B vs N/A), P/E Ratio (433.5x vs 33.3x), Revenue Growth (0.1% vs 0.2%), Gross Margin (87.9% vs 47.3%).